Alan F. Schatzberg, Charles B. Nemeroff: The American Psychiatric Press textbook of psychopharmacology. American Psychiatric Press, Washington, DC. 1998, ISBN 0-88048-817-4 (archive.org [abgerufen am 22. Mai 2023]).
D. R. Burt, I. Creese, S. H. Snyder: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. In: Science. 196 (4287), April 1977, S. 326–328. doi:10.1126/science.847477. PMID 847477
O. Adolph u. a.: Promethazine inhibits NMDA-induced currents – new pharmacological aspects of an old drug. In: Neuropharmacology. 63(2), Aug 2012, S. 280–291. doi:10.1016/j.neuropharm.2012.03.006. Epub 2012 Apr 7.
A. Doenicke, W. Lorenz: Histamine release in anaesthesia and surgery. Premedication with H1- and H2-receptor antagonists: Indications, benefits and possible problems. In: Klinische Wochenschrift. Band60, Nr.17, 1. September 1982, S.1039–1045, doi:10.1007/BF01716968.
Gudrun Hefner, Martina Hahn, Christoph Hiemke, Sermin Toto, Jan Wolff, Sibylle C. Roll, Ansgar Klimke: Pharmacodynamic Drug-Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients. In: Journal of Neural Transmission (Vienna, Austria: 1996). Band128, Nr.2, Februar 2021, S.243–252, doi:10.1007/s00702-020-02291-y, PMID 33417009.
L. Gortner: Therapeutische Hypothermie bei neonataler Asphyxie. In: Klinische Pädiatrie. Band226, Nr.01, März 2014, S.1–2, doi:10.1055/s-0033-1363276.
J. Kornhuber, M. Muehlbacher, S. Trapp, S. Pechmann, A. Friedl, M. Reichel, C. Mühle, L. Terfloth, T. Groemer, G. Spitzer, K. Liedl, E. Gulbins, P. Tripal: Identification of novel functional inhibitors of acid sphingomyelinase. In: PLoS ONE. Band6, Nr.8, 2011, S.e23852, doi:10.1371/journal.pone.0023852.
Yuri Bolshan, Matthäus Getlik, Ekaterina Kuznetsova, Gregory A. Wasney, Taraneh Hajian, Gennadiy Poda, Kong T. Nguyen, Hong Wu, Ludmila Dombrovski, Aiping Dong, Guillermo Senisterra, Matthieu Schapira, Cheryl H. Arrowsmith, Peter J. Brown, Rima Al-Awar, Masoud Vedadi, David Smil: Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. In: ACS medicinal chemistry letters. Band4, Nr.3, 14. März 2013, S.353–357, doi:10.1021/ml300467n, PMID 24900672, PMC 4027439 (freier Volltext).
Karen J. Deane, Robert L. Summers, Adele M. Lehane, Rowena E. Martin, Russell A. Barrow: Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT. In: ACS medicinal chemistry letters. Band5, Nr.5, 8. Mai 2014, S.576–581, doi:10.1021/ml5000228, PMID 24900883, PMC 4027738 (freier Volltext).
T. Nakai, N. Kitamura, T. Hashimoto, Y. Kajimoto, N. Nishino, T. Mita, C. Tanaka: Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. In: Biological Psychiatry. Band30, Nr.4, 15. August 1991, S.349–356, doi:10.1016/0006-3223(91)90290-3, PMID 1912125.
Martin Vogtherr, Susanne Grimme, Bettina Elshorst, Doris M. Jacobs, Klaus Fiebig, Christian Griesinger, Ralph Zahn: Antimalarial Drug Quinacrine Binds to C-Terminal Helix of Cellular Prion Protein. In: Journal of Medicinal Chemistry. Band46, Nr.17, 1. August 2003, S.3563–3564, doi:10.1021/jm034093h.
Gustav Ahlin, Johan Karlsson, Jenny M. Pedersen, Lena Gustavsson, Rolf Larsson, Pär Matsson, Ulf Norinder, Christel A. S. Bergström, Per Artursson: Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1. In: Journal of Medicinal Chemistry. Band51, Nr.19, 9. Oktober 2008, S.5932–5942, doi:10.1021/jm8003152.
K. Adam, I. Oswald: The hypnotic effects of an antihistamine: promethazine. In: British Journal of Clinical Pharmacology. Band22, Nr.6, Dezember 1986, S.715–717, doi:10.1111/j.1365-2125.1986.tb02962.x, PMID 3567016, PMC 1401211 (freier Volltext).
D. Fiorella, R. A. Rabin, J. C. Winter: The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. In: Psychopharmacology. 121 (3), Oktober 1995, S. 347–356. PMID 8584617
P. Seeman, M. Watanabe, D. Grigoriadis u. a.: Dopamine D2 receptor binding sites for agonists. A tetrahedral model. In: Molecular Pharmacology. 28 (5), November 1985, S. 391–399. PMID 2932631
D. R. Burt, I. Creese, S. H. Snyder: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. In: Science. 196 (4287), April 1977, S. 326–328. doi:10.1126/science.847477. PMID 847477
Gudrun Hefner, Martina Hahn, Christoph Hiemke, Sermin Toto, Jan Wolff, Sibylle C. Roll, Ansgar Klimke: Pharmacodynamic Drug-Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients. In: Journal of Neural Transmission (Vienna, Austria: 1996). Band128, Nr.2, Februar 2021, S.243–252, doi:10.1007/s00702-020-02291-y, PMID 33417009.
Contreras E, Tamayo L, Quijada L: Effects of tricyclic compounds and other drugs having a membrane stabilizing action on analgesia, tolerance to and dependence on morphine. In: Archives internationales de pharmacodynamie et de therapie. Band228, Nr.2, August 1977, PMID 562647.
Yuri Bolshan, Matthäus Getlik, Ekaterina Kuznetsova, Gregory A. Wasney, Taraneh Hajian, Gennadiy Poda, Kong T. Nguyen, Hong Wu, Ludmila Dombrovski, Aiping Dong, Guillermo Senisterra, Matthieu Schapira, Cheryl H. Arrowsmith, Peter J. Brown, Rima Al-Awar, Masoud Vedadi, David Smil: Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction. In: ACS medicinal chemistry letters. Band4, Nr.3, 14. März 2013, S.353–357, doi:10.1021/ml300467n, PMID 24900672, PMC 4027439 (freier Volltext).
Karen J. Deane, Robert L. Summers, Adele M. Lehane, Rowena E. Martin, Russell A. Barrow: Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT. In: ACS medicinal chemistry letters. Band5, Nr.5, 8. Mai 2014, S.576–581, doi:10.1021/ml5000228, PMID 24900883, PMC 4027738 (freier Volltext).
T. Nakai, N. Kitamura, T. Hashimoto, Y. Kajimoto, N. Nishino, T. Mita, C. Tanaka: Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. In: Biological Psychiatry. Band30, Nr.4, 15. August 1991, S.349–356, doi:10.1016/0006-3223(91)90290-3, PMID 1912125.
K. Adam, I. Oswald: The hypnotic effects of an antihistamine: promethazine. In: British Journal of Clinical Pharmacology. Band22, Nr.6, Dezember 1986, S.715–717, doi:10.1111/j.1365-2125.1986.tb02962.x, PMID 3567016, PMC 1401211 (freier Volltext).
